Robert Davis
Coverage of Robert Davis in the Nexus archive.
- Senator questions Merck over patent strategy for blockbuster cancer drug Keytruda
Senator Maggie Hassan is questioning Merck about its patent and pricing practices for the cancer drug Keytruda, alleging the company uses excessive patents to delay cheaper alternatives. The letter highlights concerns that Merck's strategies have kept prices high and limited patient access, with an investigation suggesting the new injectable version could delay competition until the 2030s.
- Michigan House candidate alleges anti-trans targeting; rival rejects accusation
Toni Mua, a Michigan House candidate, alleges a legal challenge against her ballot eligibility was motivated by anti-trans bias, while the activist who filed the challenge denies the claim. A court dismissed the challenge, ruling Mua's use of her current name complies with Michigan's common-law name provisions. Arthur Harrington, another candidate, denied being involved in the challenge.